Evidence map›Paper›PMID 37207594›Full record

ArticleUltrasonics2023

Pilot ex vivo study on non-thermal ablation of human prostate adenocarcinoma tissue using boiling histotripsy.

P B Rosnitskiy, S A Tsysar, M M Karzova, S V Buravkov, P G Malkov, N V Danilova, E M Ponomarchuk, O A Sapozhnikov, T D Khokhlova, G R Schade and 7 more

Open access · greenAbstract read
In one paragraph

Article in Ultrasonics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. A Fully Populated Transrectal Array for Boiling Histotripsy Ablation of the Prostate.IEEE transactions on ultrasonics, ferroelectrics, and frequency control · 2025
    Article
  6. Histotripsy: A Method for Mechanical Tissue Ablation with Ultrasound.Annual review of biomedical engineering · 2024
    Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 3 countries.

P B RosnitskiyLomonosov Moscow State University, Physics Faculty, Moscow, Russia. Electronic address: pavrosni@yandex.ru.
S A TsysarLomonosov Moscow State University, Physics Faculty, Moscow, Russia.
M M KarzovaLomonosov Moscow State University, Physics Faculty, Moscow, Russia.
S V BuravkovLomonosov Moscow State University, Faculty of Fundamental Medicine, Moscow, Russia.
P G MalkovLomonosov Moscow State University, Medical Research and Educational Center, Moscow, Russia.
N V DanilovaLomonosov Moscow State University, Medical Research and Educational Center, Moscow, Russia.
E M PonomarchukLomonosov Moscow State University, Physics Faculty, Moscow, Russia.
O A SapozhnikovLomonosov Moscow State University, Physics Faculty, Moscow, Russia; University of Washington, Applied Physics Laboratory, Center for Industrial and Medical Ultrasound, Seattle, WA, USA.
T D KhokhlovaUniversity of Washington School of Medicine, Department of Medicine, Division of Gastroenterology, Seattle, WA, USA.
G R SchadeUniversity of Washington School of Medicine, Department of Urology, Seattle, WA, USA.
A D MaxwellUniversity of Washington School of Medicine, Department of Urology, Seattle, WA, USA.
Y-N WangUniversity of Washington, Applied Physics Laboratory, Center for Industrial and Medical Ultrasound, Seattle, WA, USA.
A V KadrevLomonosov Moscow State University, Medical Research and Educational Center, Moscow, Russia; Russian Medical Academy of Continuous Professional Education, Diagnostic Ultrasound Division, Moscow, Russia.
A L ChernyaevPulmonology Scientific Research Institute, Moscow, Russia.
D A OkhobotovUniversity of Washington, Applied Physics Laboratory, Center for Industrial and Medical Ultrasound, Seattle, WA, USA.
A A KamalovUniversity of Washington, Applied Physics Laboratory, Center for Industrial and Medical Ultrasound, Seattle, WA, USA.
V A KhokhlovaLomonosov Moscow State University, Physics Faculty, Moscow, Russia; University of Washington, Applied Physics Laboratory, Center for Industrial and Medical Ultrasound, Seattle, WA, USA.
Lomonosov Moscow State University · RUUniversity of Washington · USUniversity of Washington Applied Physics Laboratory · US

Funding

Transrectal Histotripsy for Focal Ablation of Prostate CancerR01CA258581 · NCI · UNIVERSITY OF WASHINGTON · PI SCHADE, GEORGE R · 2022 to 2025
$3.1M
NCI NIH HHS R01 CA258581
6 · The paper itself

Abstract

Focused ultrasound technologies are of growing interest for noninvasive ablation of localized prostate cancer (PCa). Here we present the results of the first case study evaluating the feasibility of non-thermal mechanical ablation of human prostate adenocarcinoma tissue using the boiling histotripsy (BH) method on ex vivo tissue. High intensity focused ultrasound field was generated using a 1.5-MHz custom-made transducer with nominal F#=0.75. A sonication protocol of 734 W acoustic power, 10-ms long BH-pulses, 30 pulses per focal spot, 1 % duty cycle, and 1 mm distance between single foci was tested in an ex vivo human prostate tissue sample containing PCa. The protocol used here has been successfully applied in the previous BH studies for mechanical disintegration of ex vivo prostatic human tissue with benign hyperplasia. BH treatment was monitored using B-mode ultrasound. Post-treatment histologic analysis demonstrated BH produced liquefaction of the targeted tissue volume. BH treated benign prostate parenchyma and PCa had similar tissue fractionation into subcellular fragments. The results of the study demonstrated that PCa tumor tissue can be mechanically ablated using the BH method. Further studies will aim on optimizing protocol parameters to accelerate treatment while maintaining complete destruction of the targeted tissue volume into subcellular debris.

Indexed as

AdenocarcinomaHigh-Intensity Focused Ultrasound AblationProstatic NeoplasmsHumansMaleProstateUltrasonographyCancerHIFUHistotripsyProstateTreatment planning

Identifiers

PMID37207594
PMCPMC10438901
OpenAlexW4375845661

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.